Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Harvard Bioscience (NASDAQ: HBIO) will report financial results for the quarter ended September 30, 2025 before market open on November 6, 2025. The company will host a conference call to discuss results at 8:00 AM Eastern Time on the same day.
Participants who wish to ask questions must register to receive dial-in numbers and a unique PIN. An audio-only webcast will be available via the company’s Investor Relations events and presentations page. The earnings release and related slide presentation will be posted in the Investor Relations section.
Harvard Bioscience (NASDAQ: HBIO) comunicherà i risultati finanziari del trimestre terminato 30 settembre 2025 prima dell'apertura del mercato il 6 novembre 2025. L'azienda terrà una teleconferenza per discutere i risultati alle 8:00 ora orientale nello stesso giorno.
I partecipanti che desiderano porre domande devono registrarsi per ricevere i numeri di accesso e un PIN univoco. Una trasmissione audio in streaming sarà disponibile tramite la pagina degli eventi e delle presentazioni delle Relazioni con gli Investitori dell'azienda. Il comunicato sugli utili e la relativa presentazione di diapositivi saranno pubblicati nella sezione Relazioni con gli Investitori.
Harvard Bioscience (NASDAQ: HBIO) reportará los resultados financieros del trimestre terminado el 30 de septiembre de 2025 antes de la apertura del mercado el 6 de noviembre de 2025. La empresa realizará una conferencia telefónica para comentar los resultados a las 8:00 a.m. hora del Este en el mismo día.
Los participantes que deseen hacer preguntas deben registrarse para recibir números de marcación y un PIN único. Habrá una transmisión de audio por Internet disponible a través de la página de Eventos y Presentaciones de Relaciones con Inversores de la empresa. El comunicado de resultados y la presentación de diapositivas relacionada se publicarán en la sección de Relaciones con Inversores.
Harvard Bioscience (나스닥: HBIO)는 2025년 9월 30일에 종료된 분기의 재무 실적을 2025년 11월 6일 시장 개장 전 발표합니다. 같은 날 동부 시간 8:00 AM에 결과를 논의하기 위한 컨퍼런스 콜을 주최합니다.
질문을 하고 싶은 참가자는 다이얼 인 번호와 고유 PIN을 받기 위해 등록해야 합니다. 오디오 전용 웹캐스트가 기업의 투자자 관계 이벤트 및 발표 페이지를 통해 제공됩니다. 실적 발표 및 관련 슬라이드 프리젠테이션은 투자자 관계 섹션에 게시됩니다.
Harvard Bioscience (NASDAQ: HBIO) publiera les résultats financiers du trimestre clos le 30 septembre 2025 avant l'ouverture du marché le 6 novembre 2025. L'entreprise organisera une conférence téléphonique pour discuter des résultats à 8h00, heure de l'Est le même jour.
Les participants qui souhaitent poser des questions doivent s'inscrire pour recevoir des numéros d'accès et un code PIN unique. Une webdiffusion audio uniquement sera disponible via la page des Événements et Présentations des Relations Investisseurs de l'entreprise. Le communiqué de résultats et la présentation associée seront publiés dans la section Relations Investisseurs.
Harvard Bioscience (NASDAQ: HBIO) wird die finanziellen Ergebnisse des Quartals, das am 30. September 2025 endete, vor Börsenöffnung am 6. November 2025 bekannt geben. Das Unternehmen wird an diesem Tag um 8:00 Uhr Eastern Time eine Konferenzschaltung abhalten, um die Ergebnisse zu erläutern.
Teilnehmer, die Fragen stellen möchten, müssen sich registrieren, um Einwahlnummern und eine eindeutige PIN zu erhalten. Eine reine Audio-Webcast wird über die Investor Relations-Veranstaltungen und Präsentationen des Unternehmens verfügbar sein. Die Gewinnmitteilung und die zugehörige Folienpräsentation werden im Bereich Investor Relations veröffentlicht.
هاورد بايوساينس (بورصة ناسداك: HBIO) ستعلن عن النتائج المالية للربع المنتهي في 30 سبتمبر 2025 قبل افتتاح السوق في 6 نوفمبر 2025. ستعقد الشركة مكالمة مؤتمراتية لمناقشة النتائج في الساعة 8:00 صباحاً بتوقيت شرق الولايات المتحدة في اليوم نفسه.
المشاركون الذين يرغبون في طرح أسئلة يجب أن يسجلوا للحصول على أرقام الاتصال ورقم PIN فريد. ستكون هناك بث صوتي فقط عبر الويب متاح عبر صفحة فعاليات وأعمال علاقات المستثمرين لدى الشركة. سيتم نشر بيان الأرباح والعرض التقديمي المتعلق به في قسم علاقات المستثمرين.
- None.
- None.
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Company Contact:
Mark Frost
Interim Chief Financial Officer
(508) 893-3120
investors@harvardbioscience.com
 
    
      
  
 
             
             
             
             
             
             
             
             
             
         
         
         
        